Physician profile
David J Rallis
NPI 1275500076
$778,579.14
in general payments reported to CMS, 2019-2025
9 companies · $3,921 in 2025
The $3,921 reported for 2025 was more than what 96% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $80K · 2021: $334K · 2022: $323K · 2023: $945 · 2024: $1,593 · 2025: $3,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,533 · Travel and Lodging: $2,058 · Gift: $716 · Entertainment: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,532.93 |
| Travel and Lodging | $2,057.60 |
| Gift | $715.53 |
| Entertainment | $153.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $776,092.50 | 2019-2025 | |
| Henry Schein, INC. | $1,614.39 | 2019-2024 | |
| Kerr Corporation | $230.05 | 2022 | |
| Nobel Biocare USA | $180.00 | 2023 | Nobelactive |
| Ormco Corporation | $180.00 | 2023 | |
| Salvin Dental Specialties, INC. | $90.39 | 2019 | |
| Biohorizons Implant Systems INC. | $76.13 | 2024 | Biohorizons |
| Zimvie INC. | $73.00 | 2023 | |
| Dentsply Sirona INC | $42.68 | 2024 | Suresmile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.